pH Pharma Co. Revenue and Competitors
Estimated Revenue & Valuation
- pH Pharma Co.'s estimated annual revenue is currently $12.6M per year.
- pH Pharma Co.'s estimated revenue per employee is $155,000
Employee Data
- pH Pharma Co. has 81 Employees.
- pH Pharma Co. grew their employee count by -10% last year.
pH Pharma Co.'s People
Name | Title | Email/Phone |
---|---|---|
1 | Interim Head HR | Reveal Email/Phone |
pH Pharma Co. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is pH Pharma Co.?
pH Pharma's vision is focused on developing innovative healthcare products for high unmet clinical and consumer needs. Our aspiration is to drive innovative cross-border transactions, transparent management, and engine for developing future leaders. ?pH? is a numeric scale used to specify the acidity or alkalinity of an aqueous solutions. We will utilize our scientific and business judgment to decide on investment criteria and to construct a balanced portfolio of innovative healthcare technologies/products.
keywords:N/AN/A
Total Funding
81
Number of Employees
$12.6M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
pH Pharma Co. News
Moreover, the BOI is actively promoting the Philippines as a manufacturing hub for pharmaceutical companies to produce Covid-19 medicines...
Bryan Mazlish, co-founder and CEO, set out why the technology is ... as well as the omicron variant by fall, CEO Albert Bourla, Ph.D.,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 81 | 3% | N/A |
#2 | $11.5M | 82 | 26% | $31M |
#3 | $20.6M | 82 | 32% | N/A |
#4 | N/A | 82 | 52% | N/A |
#5 | $19.9M | 82 | 5% | N/A |